Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Coller

Showing results (71-80 of 163) with videos related to

Pageof 17
Sort By:
Thrombosis Research|June 1, 1975
Studies on the Factor VIII/von Willebrand factor antigen on human plateletsB S Coller, R J Hirschman, H R Gralnick
Blood|May 1, 1976
The pH dependence of quantitative ristocetin-induced platelet aggregation: theoretical and practical implications-a new device for maintenance of platelet-rich plasma pHB S Coller, B R Franza, H R Gralnick
Haemostasis|October 1, 1996
The anti-GPIIb-IIIa agents: fundamental and clinical aspectsB S Coller, K M Anderson, H F Weisman
Methods in Enzymology|January 1, 1992
Preparation and functional characterization of monoclonal antibodies against glycoprotein IbL E Scudder, E L Kalomiris, B S Coller
American Journal of Hematology|January 1, 1977
Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsiesB S Coller, B A Chabner, H R Gralnick
Blood|October 1, 1984
Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombinH R Gralnick, S B Williams, B S Coller
Blood|January 1, 1992
Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptorJ H Beer, K T Springer, B S Coller
The New England Journal of Medicine|October 22, 1987
Plasma glycocalicin. An aid in the classification of thrombocytopenic disordersM H Steinberg, J G Kelton, B S Coller
Anesthesia and Analgesia|December 1, 1996
The effects of thrombocytopenia on the activated coagulation timeT Ammar, C F Fisher, K Sarier, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1991
The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in IsraelP J Newman, U Seligsohn, S Lyman, et al.
Pageof 17

Showing results (71-80 of 163) with videos related to

Sort By:
Pageof 17
Thrombosis Research|June 1, 1975
Studies on the Factor VIII/von Willebrand factor antigen on human plateletsB S Coller, R J Hirschman, H R Gralnick
Blood|May 1, 1976
The pH dependence of quantitative ristocetin-induced platelet aggregation: theoretical and practical implications-a new device for maintenance of platelet-rich plasma pHB S Coller, B R Franza, H R Gralnick
Haemostasis|October 1, 1996
The anti-GPIIb-IIIa agents: fundamental and clinical aspectsB S Coller, K M Anderson, H F Weisman
Methods in Enzymology|January 1, 1992
Preparation and functional characterization of monoclonal antibodies against glycoprotein IbL E Scudder, E L Kalomiris, B S Coller
American Journal of Hematology|January 1, 1977
Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsiesB S Coller, B A Chabner, H R Gralnick
Blood|October 1, 1984
Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombinH R Gralnick, S B Williams, B S Coller
Blood|January 1, 1992
Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptorJ H Beer, K T Springer, B S Coller
The New England Journal of Medicine|October 22, 1987
Plasma glycocalicin. An aid in the classification of thrombocytopenic disordersM H Steinberg, J G Kelton, B S Coller
Anesthesia and Analgesia|December 1, 1996
The effects of thrombocytopenia on the activated coagulation timeT Ammar, C F Fisher, K Sarier, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1991
The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in IsraelP J Newman, U Seligsohn, S Lyman, et al.
Pageof 17